These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
326 related articles for article (PubMed ID: 22042246)
1. A new cyclopamine glucuronide prodrug with improved kinetics of drug release. Renoux B; Legigan T; Bensalma S; Chadéneau C; Muller JM; Papot S Org Biomol Chem; 2011 Dec; 9(24):8459-64. PubMed ID: 22042246 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluations of a monomethylauristatin E glucuronide prodrug for selective cancer chemotherapy. Legigan T; Clarhaut J; Renoux B; Tranoy-Opalinski I; Monvoisin A; Jayle C; Alsarraf J; Thomas M; Papot S Eur J Med Chem; 2013 Sep; 67():75-80. PubMed ID: 23845743 [TBL] [Abstract][Full Text] [Related]
3. Study of a cyclopamine glucuronide prodrug for the selective chemotherapy of glioblastoma. Hamon F; Renoux B; Chadéneau C; Muller JM; Papot S Eur J Med Chem; 2010 Apr; 45(4):1678-82. PubMed ID: 20116904 [TBL] [Abstract][Full Text] [Related]
4. Extended scaffold glucuronides: en route to the universal synthesis of O-aryl glucuronide prodrugs. Walther R; Jarlstad Olesen MT; Zelikin AN Org Biomol Chem; 2019 Jul; 17(29):6970-6974. PubMed ID: 31290904 [TBL] [Abstract][Full Text] [Related]
5. A heterodimeric glucuronide prodrug for cancer tritherapy: the double role of the chemical amplifier. Grinda M; Clarhaut J; Tranoy-Opalinski I; Renoux B; Monvoisin A; Cronier L; Papot S ChemMedChem; 2011 Dec; 6(12):2137-41. PubMed ID: 21815268 [No Abstract] [Full Text] [Related]
6. New Taxol (paclitaxel) prodrugs designed for ADEPT and PMT strategies in cancer chemotherapy. Alaoui AE; Saha N; Schmidt F; Monneret C; Florent JC Bioorg Med Chem; 2006 Jul; 14(14):5012-9. PubMed ID: 16554162 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of the suberoylanilide hydroxamic acid (SAHA) beta-glucuronide and beta-galactoside for application in selective prodrug chemotherapy. Thomas M; Rivault F; Tranoy-Opalinski I; Roche J; Gesson JP; Papot S Bioorg Med Chem Lett; 2007 Feb; 17(4):983-6. PubMed ID: 17157009 [TBL] [Abstract][Full Text] [Related]
8. Benzyl ether-linked glucuronide derivative of 10-hydroxycamptothecin designed for selective camptothecin-based anticancer therapy. Leu YL; Chen CS; Wu YJ; Chern JW J Med Chem; 2008 Mar; 51(6):1740-6. PubMed ID: 18318465 [TBL] [Abstract][Full Text] [Related]
9. Selective release of a cyclopamine glucuronide prodrug toward stem-like cancer cell inhibition in glioblastoma. Balbous A; Renoux B; Cortes U; Milin S; Guilloteau K; Legigan T; Rivet P; Boissonnade O; Martin S; Tripiana C; Wager M; Bensadoun RJ; Papot S; Karayan-Tapon L Mol Cancer Ther; 2014 Sep; 13(9):2159-69. PubMed ID: 25053823 [TBL] [Abstract][Full Text] [Related]
10. A humanized immunoenzyme with enhanced activity for glucuronide prodrug activation in the tumor microenvironment. Chen KC; Wu SY; Leu YL; Prijovich ZM; Chen BM; Wang HE; Cheng TL; Roffler SR Bioconjug Chem; 2011 May; 22(5):938-48. PubMed ID: 21443266 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and one-electron reduction characteristics of radiation-activated prodrugs possessing two 5-fluorodeoxyuridine units. Tanabe K; Sugiura M; Ito T; Nishimoto S Bioorg Med Chem; 2012 Sep; 20(17):5164-8. PubMed ID: 22847019 [TBL] [Abstract][Full Text] [Related]
12. Heparin-paclitaxel conjugates as drug delivery system: synthesis, self-assembly property, drug release, and antitumor activity. Wang Y; Xin D; Liu K; Zhu M; Xiang J Bioconjug Chem; 2009 Dec; 20(12):2214-21. PubMed ID: 19950889 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of glucuronide prodrugs of the histone deacetylase inhibitor CI-994 for application in selective cancer chemotherapy. Thomas M; Clarhaut J; Tranoy-Opalinski I; Gesson JP; Roche J; Papot S Bioorg Med Chem; 2008 Sep; 16(17):8109-16. PubMed ID: 18692397 [TBL] [Abstract][Full Text] [Related]
14. Synthesis of self-immolative glucuronide-based prodrugs of a phenol mustard. Lougerstay-Madec R; Florent JC; Monneret C; Nemati F; Poupon MF Anticancer Drug Des; 1998 Dec; 13(8):995-1007. PubMed ID: 10335272 [TBL] [Abstract][Full Text] [Related]
15. Antitumor activity of extracts and compounds from the rhizomes of Veratrum dahuricum. Tang J; Li HL; Shen YH; Jin HZ; Yan SK; Liu RH; Zhang WD Phytother Res; 2008 Aug; 22(8):1093-6. PubMed ID: 18570211 [TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and in vitro evaluation of β-glucuronidase-sensitive prodrug of 5-aminolevulinic acid for photodiagnosis of breast cancer cells. Herceg V; Adriouach S; Janikowska K; Allémann E; Lange N; Babič A Bioorg Chem; 2018 Aug; 78():372-380. PubMed ID: 29627657 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and anticancer activity studies of cyclopamine derivatives. Zhang J; Garrossian M; Gardner D; Garrossian A; Chang YT; Kim YK; Chang CW Bioorg Med Chem Lett; 2008 Feb; 18(4):1359-63. PubMed ID: 18221872 [TBL] [Abstract][Full Text] [Related]
18. Preparation of a camptothecin prodrug with glutathione-responsive disulfide linker for anticancer drug delivery. Xu Z; Wang D; Xu S; Liu X; Zhang X; Zhang H Chem Asian J; 2014 Jan; 9(1):199-205. PubMed ID: 24136878 [TBL] [Abstract][Full Text] [Related]
19. Synthesis of cyclopamine using a biomimetic and diastereoselective approach. Giannis A; Heretsch P; Sarli V; Stössel A Angew Chem Int Ed Engl; 2009; 48(42):7911-4. PubMed ID: 19591183 [No Abstract] [Full Text] [Related]
20. Synthesis and biological studies of the thiols-triggered anticancer prodrug for a more effective cancer therapy. Xu Y; Chen J; Li Y; Peng S; Gu X; Sun M; Gao K; Fang J Org Biomol Chem; 2015 Mar; 13(9):2634-9. PubMed ID: 25581090 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]